Press release
Companion Diagnostics Market worth $9.9 billion by 2026 - Leading Key Players are Agilent Technologies, Inc. (US), Qiagen N.V. (Germany), Thermo Fisher Scientific, Inc. (US)
Companion Diagnostics Market
Browse in-depth TOC on "Companion Diagnostics Market"
322 - Tables
51 - Figures
331 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr
The policy programs to provide effective care to patients with cancer, high drug development activity, structured regulatory framework in the region, and large patient pool undergoing advanced medical testing. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the companion diagnostics market.
The assays, kits & reagents segment accounted for the largest share of the companion diagnostics market, by product & service segment, in 2020
The companion diagnostics market is segmented into assays, kits & reagents, and software & services. The assays, kits & reagents accounted for the largest share of the companion diagnostics market in 2020, mainly due to the availability of a wide range of products and increasing use of assays and kits in different therapeutic areas.
PCR segment to register the highest growth rate during the forecast period
The companion diagnostics market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridization (ISH), immunohistochemistry (IHC), and other technologies. In 2020, the PCR segment accounted for the largest share of the companion diagnostics market. Factors such as the ease of use and widespread availability of PCR kits & reagents in companion diagnostic testing, and growing applications of PCR in the high-throughput detection of mutants with a limited or low allele frequency of genes.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155571681&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr
Cancer segment to register the highest growth rate during the forecast period
The companion diagnostics market is segmented into cancer, cardiovascular diseases (CVDs), neurological diseases, infectious diseases, and other indications (inflammatory and inherited diseases, among others). In 2020, the cancer segment accounted for the largest share of the companion diagnostics market. Factors such as growing role of companion diagnostics in the personalized medicine treatment for cancer, and increasing utility of biomarkers in the diagnosis of cancer.
The pharmaceutical & biotechnology companies segment accounted for the largest share of the companion diagnostics market, by end user segment, in 2020
Based on end user, the companion diagnostics market is segmented into pharmaceutical & biotechnology companies, reference laboratories, CROs, and other end users (including physician & hospital laboratories, and academic medical centers). In 2020, pharmaceutical & biotechnology companies accounted for a larger share of the companion diagnostics market. The growing use of companion diagnostics owing to their increasing prominence in drug development, and the increasing importance of companion diagnostic biomarkers.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=155571681&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr
North America is the largest regional market for companion diagnostics market
The global companion diagnostics market is segmented into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the companion diagnostics market. The North American companion diagnostics market growth can be attributed to the presence of many leading companion diagnostics vendors & national clinical laboratories, the easy accessibility to technologically advanced devices and instruments, and the highly developed healthcare system in the US and Canada.
The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Qiagen N.V. (Germany), Thermo Fisher Scientific, Inc. (US), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), Abnova Corporation (Taiwan), Guardant Health, Inc. (US), ICON Plc (Ireland), BioGenex Laboratories, Inc. (US), Invivoscribe Technologies (US), ArcherDX, Inc. (US), NG Biotech (France), Q² Solutions (US), Amoy Diagnostics Co., Ltd. (China), Abacus Diagnostica Oy (Finland), Asuragen Inc. (US), SAGA Diagnostics (Sweden), Meso Scale Diagnostics, LLC. (US), and Creative Biolabs (US).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics Market worth $9.9 billion by 2026 - Leading Key Players are Agilent Technologies, Inc. (US), Qiagen N.V. (Germany), Thermo Fisher Scientific, Inc. (US) here
News-ID: 2553987 • Views: …
More Releases from MarketsandMarkets™ INC
Microscopy Market worth $9.5 billion by 2027 - Exclusive Report by MarketsandMar …
Microscopy Market is projected to grow from USD 7.2 billion in 2022 to USD 9.5 billion by 2027, at a CAGR of 5.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. Factors such as advancement in technology of microscopes, growing interest of nanotechnology and regenerative medicines, better regulatory procedures along with growing application scope and high demand from key end users are driving the market growth. Moreover,…
Bariatric Surgery Devices Market worth $2.4 billion by 2027 - Exclusive Report b …
Bariatric Surgery Devices Market is projected to grow from USD 1.9 billion in 2022 to USD 2.4 billion by 2027, at a CAGR of 5.4% from 2022 to 2027, according to a new report by MarketsandMarkets™. Emerging countries have offered significant growth opportunities to major market players, which is further expected to support market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173150134
Browse in-depth TOC on "Bariatric Surgery Devices Market"
130 - Tables
35 -…
Veterinary Diagnostics Market worth $4.4 billion by 2027 - Exclusive Report by M …
Veterinary Diagnostics Market is projected to grow from USD 2.8 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 9.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth can largely be attributed to the growth in the companion animal population, the increasing incidence of transboundary and zoonotic diseases and the rising demand for animal-derived food products. A surge in the overall…
Nuclear Medicine Market by 2026 - Global Trends, Share Analysis, Leading Players …
The nuclear medicine market is projected to reach USD 7.5 billion by 2026, growing at a CAGR of 9.0% during the forecast period.
Increasing incidence and prevalence of target conditions;
The rising incidence and prevalence of cancer and cardiovascular disease (CVD) is a key factor supporting market growth. Most cases can be prevented through early detection and treatment; nuclear medicine plays a significant role in these areas. According to the WHO, cancer…
More Releases for Diagnostics
Covid-19 Diagnostic Market is Booming Worldwide By Top Key Players: Abbott Diagn …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Covid-19 Diagnostic market. Players can use the accurate…
What are the Growth Drivers of Covid-19 Diagnostic Market? BD Diagnostics, Abbot …
Market Study Report LLC recently added a new title on 2020-2025 Global Covid-19 Diagnostic Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2025.
The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact…
North America Autoimmune Disease Diagnostics Market (2020-2026) | Abbott Laborat …
According to the Graphical Research new growth forecast report titled "North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Industry Analysis Report, Regional Outlook (U.S., Canada)", Estimated To Exceed USD 6.5 Billion By 2026. Autoimmune diagnostic procedures have increased demand for instruments and services for rapid and effective outcomes. Rising adoption of lab automation technology will foster…
Covid-19 Diagnostic Market Overall Study Report 2020-2026 | Abbott Diagnostics, …
This report focuses on Covid-19 Diagnostic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Covid-19 Diagnostic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Get Free Sample PDF Copy at https://www.reportsnreports.com/contacts/requestsample.aspx?name=3095138.
Top Key Players in the Global Covid-19 Diagnostic Market Include: -
o Abbott Diagnostics
o …
Global Allergy Diagnostics Market 2020 Lincoln Diagnostics, Hitachi Chemical Dia …
Global Allergy Diagnostics Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments
The research report on the global Allergy Diagnostics market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer…
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report.
Get Sample Copy of this Report @…
